[1]
“Retrospective analysis of severe cutaneous adverse drug reactions over a period of 6 years”, J Pak Assoc Dermatol, vol. 30, no. 4, pp. 544–549, Jan. 2021, doi: 10.66344/jpad.v30i4.1442.